0.21
+2.99%
Close of 9 Nov 2026, in EUR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Biotechnology Assets
Its shares trade on BME under the ticker BST.MC. It has been listed since 14 June 2011. In the fiscal year to 31 December 2025, it reported revenue of €3.1m and a net loss of €1.9m. At that date it held total assets of €13.6m and shareholders' equity of €6.2m.
ADL Bionatur Solutions SA operates as a biopharmaceutical company. The company is headquartered in Jerez De La Frontera, Cadiz. The company went IPO on 2011-06-14. Among the chemical projects, the Company comprises the examination and interpretation of samples from waste treatment works, valuation of biological activities and retrosynthetic analysis. The firm's subsidiaries are BBD BioPhenix SL, a San Sebastian-based biotechnology company and Zera Intein Protein Solutions SL.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Biotechnology
- Listed since
- 14 Jun 2011
- Employees
- 344
- Website
- bionaturis.com ↗
Leadership
Pay as last reported
- Mr. Victor Manuel Infante VinoloChairman of the Board, since 2022
- Mr. John DixonDirector
- Mr. Jeronimo Herrero MansoDirector
- Mr. Andres Seco GarciaDirector
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- ADL Bionatur Solutions SA possesses several strengths that contribute to its competitive advantage in the market. Firstly, the company has a strong portfolio of innovative and high-quality bio-based solutions, which sets it apart from its competitors. Its expertise in biotechnology and sustainable solutions enables it to develop and offer unique products that meet the evolving needs of customers.
- Secondly, ADL Bionatur Solutions SA has a robust research and development team, dedicated to continuous improvement and new product development. This allows the company to stay at the forefront of technological advancements in the industry and maintain its position as an innovation leader.
- Additionally, the company benefits from strategic partnerships with key players in the bio-based solutions market. These alliances provide access to new markets, distribution channels, and resources, enhancing ADL Bionatur Solutions SA's market reach and brand recognition.
Weaknesses
- Despite its strengths, ADL Bionatur Solutions SA also faces a few weaknesses that could hinder its growth and competitiveness. One of these weaknesses is the company's relatively small size compared to some of its competitors. This may limit its capacity to invest in large-scale production and distribution facilities, potentially impacting its ability to efficiently meet growing market demand.
- Another weakness lies in the limited geographic presence of ADL Bionatur Solutions SA. The company currently operates primarily in specific regions, which makes it more susceptible to fluctuations in local market conditions and economic challenges.
Opportunities
- ADL Bionatur Solutions SA operates in a sector with significant growth potential and numerous opportunities. One of these opportunities is the increasing global demand for sustainable and eco-friendly solutions. As consumers and businesses become more environmentally-conscious, there is a growing market for ADL Bionatur Solutions SA's bio-based products.
- Additionally, the expanding preference for natural and organic ingredients in various industries, such as cosmetics, agriculture, and food, presents opportunities for ADL Bionatur Solutions SA to further diversify and expand its product offerings.
Threats
- Despite the favorable market conditions, ADL Bionatur Solutions SA faces certain threats that could impact its operations and profitability. One significant threat is the presence of intense competition within the bio-based solutions industry. Other companies, including multinational corporations, may offer similar products or enter the market with competitive innovations, posing a challenge to ADL Bionatur Solutions SA's market share.
- Furthermore, regulatory changes and policies related to the use of bio-based products and chemicals may pose compliance challenges and impact the demand for ADL Bionatur Solutions SA's offerings. The company must closely monitor and adapt to changing regulations to avoid any negative consequences.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.